Artelo Biosciences, Inc. (ARTL) Tops Q3 EPS by 44c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q3 EPS of ($0.35), $0.44 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
• Bang Mai Fang files for 5M share IPO at $5-$6/sh
• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development